Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04456790
Other study ID # PHT/2019/32
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 25, 2020
Est. completion date January 14, 2021

Study information

Verified date March 2021
Source Portsmouth Hospitals NHS Trust
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Questionnaire study exploring patients preference in bowel preparation timings for morning colonoscopy.


Description:

It is often difficult to achieve optimal bowel cleansing for patients having morning colonoscopies. One possible cause of this is the timing of the bowel preparation prior to the procedure. A clean bowel will allow for a clear view of its inner lining which is important for both accurate diagnosis and treatment. Abnormal changes may be tiny, so even the smallest amount of faeces could potentially disguise polyps and cancers. Additionally, poor bowel cleansing can lead to the procedure being cancelled and repeated on another occasion at a later date, adding to the burden on current resources. Poor bowel preparation has also been shown to be a factor in more difficult and longer procedures, increased patient discomfort, and a higher risk of complications. This is more of an issue for patients having a colonoscopy in the morning. One cause of this could be the timing of bowel preparation. Studies have shown that having a smaller window of time between finishing bowel preparation and having a colonoscopy results in a much cleaner bowel. The investigators are therefore considering the times patients are required to take their bowel preparation in order to improve the bowel cleansing outcome for a morning colonoscopy. Previous studies have indicated that a split dose (one evening dose and one early morning dose) improves bowel cleansing compared to all doses taken the day prior to colonoscopy. However, there has been no research to assess the efficacy of early morning bowel preparation and its acceptability to patients. This information may lead to future studies and in order to ensure the success of this further research it is important to understand any potential barriers from patients to new timing regimens. Therefore, such information as highest education level, employment status, age and experience of previous bowel preparation for colonoscopy for the patient population is captured. Results from previous studies looking at potential barriers have shown that such issues as having a simplified colonoscopy instruction sheet improved bowel preparation and lowered cancellation rates and that patients with a history of colonoscopy are less likely to follow bowel preparation instructions and therefore achieve adequate bowel cleansing. A total of 300 participants will be approached; 150 participants who have previously had bowel preparation for colonoscopy and 150 participants who have not, and are attending for a flexi sigmoidoscopy and therefore may have to go on to have a colonoscopy. These groups will be further split to half attending in the morning and half attending in the afternoon, thus achieving a cross section of this patient group.


Recruitment information / eligibility

Status Completed
Enrollment 304
Est. completion date January 14, 2021
Est. primary completion date January 14, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - • Attending the endoscopy suite at Portsmouth Hospitals NHS Trust for colonoscopy or flexi-sigmoidoscopy procedures - Aged 18 years and above - Participant is willing and able to give informed consent for participation in the study Exclusion Criteria: - • Aged under 18 years - Unable to complete the questionnaire unsupervised

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United Kingdom Portsmouth Hospitals NHS Trust Portsmouth Wessex

Sponsors (1)

Lead Sponsor Collaborator
Portsmouth Hospitals NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient preferences questionnaire Patients to rate their preference for timings from 1st to third choice. 3 months
Secondary Patient preferences questionnaire To establish the reasons for expressed preferences for bowel preparation timings 3 months
See also
  Status Clinical Trial Phase
Completed NCT02265939 - Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy Phase 2
Completed NCT04659590 - Exploratory Study of Rectal Mucus for Diagnosing Disease
Recruiting NCT06059989 - inDuctIon tREatment With subCuTaneous Infliximab for Crohn's Disease Phase 3
Completed NCT02963246 - Mindfulness Therapy in Inflammatory Bowel Disease N/A
Completed NCT03198871 - IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population Phase 4
Completed NCT02980562 - Comparison of Low Volume PEG-Asc and Lower Volume PEG-Asc With Bisacodyl Phase 3
Completed NCT03860779 - Biopotentials for Clinician Satisfaction With Sedation in Colonoscopy
Not yet recruiting NCT05406934 - Evaluation of Blood Platelet Indices,Platelet Aggregation in the Activity of IBD Patients on Biological Treatment
Completed NCT06464484 - The Effects Of Probiotics On Stress Among Healthy Adults From Umm Al-Qura University At Makkah N/A
Recruiting NCT04937868 - Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
Not yet recruiting NCT05473325 - Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
Recruiting NCT06152289 - Development of New Diagnostic Tools in Capsule Endoscopy
Active, not recruiting NCT04959123 - Does the Common Practice of Adding Diluted Epinephrine in Tranverse Abdominal Plan Block to Ropivacaine Significantly Decrease the Peak Systemic Resorption of Ropivacaine? N/A
Active, not recruiting NCT06321614 - Deep Learning in Classifying Bowel Obstruction Radiographs
Completed NCT04097574 - Study of NPO-13 During Colonoscopy Phase 2
Terminated NCT04032756 - Tofacitinib Registry of Patients With Ulcerative Colitis in Germany
Withdrawn NCT04021264 - The Impact of an Epidural Anesthetic on the Consumption of Sevoflurane in Major Abdominal Surgery Phase 2/Phase 3
Recruiting NCT05224089 - Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy Phase 4
Not yet recruiting NCT04767633 - Picoprep Split-dose Before Colonoscopy in Children Phase 3